Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Atrion Corporation ATRI
$555.00
-$7.65 (-1.38%)
На 18:01, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
985925606.00000000
-
week52high
705.74
-
week52low
534.99
-
Revenue
183506000
-
P/E TTM
31
-
Beta
0.47128000
-
EPS
19.56000000
-
Last Dividend
8.60000000
-
Next Earnings Date
08 мая 2023 г. в 10:59
Описание компании
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
BWS Financial | Sell | 25 апр 2016 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
STUPP JOHN P JR | A | 551 | 36 | 03 янв 2023 г. |
STUPP JOHN P JR | A | 515 | 7 | 03 янв 2023 г. |
STRICKLAND JEFFERY | A | 137 | 2 | 03 янв 2023 г. |
STRICKLAND JEFFERY | D | 1302 | 80 | 28 окт 2022 г. |
STRICKLAND JEFFERY | D | 1382 | 150 | 27 окт 2022 г. |
STRICKLAND JEFFERY | D | 1532 | 1000 | 26 окт 2022 г. |
STRICKLAND JEFFERY | D | 135 | 339 | 25 авг 2022 г. |
STRICKLAND JEFFERY | D | 474 | 2 | 25 авг 2022 г. |
STRICKLAND JEFFERY | D | 2532 | 82 | 25 авг 2022 г. |
STRICKLAND JEFFERY | A | 2614 | 338 | 25 авг 2022 г. |
Новостная лента
Dividend Champion, Contender, And Challenger Highlights: Week Of March 26
Seeking Alpha
25 мар 2023 г. в 10:44
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
Dividend Champion, Contender, And Challenger Highlights: Week Of March 12
Seeking Alpha
11 мар 2023 г. в 09:08
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
Atrion: Fair And Reasonably Priced For Resiliency Premium
Seeking Alpha
08 дек 2022 г. в 02:24
Record third quarter revenue, with upsides observed across the product portfolio. Strong return on capital coupled with free cash outflows, a key finding that pulled through from previous analysis.
Atrion: Attractively Priced For Exposure To Defensive Healthcare
Seeking Alpha
08 сент 2022 г. в 11:30
Artrion Corp. looks well positioned to continue delivering stable, predictable future cash flows. The stock is ideal for those seeking defensive characteristics into equity portfolios.